Table 1.
The relationship between LINC00511 and clinicopathologic characteristics in the validated cohort.
| Clinicopathologic characteristics | Low expression (%) | High expression (%) | X2 | P |
|---|---|---|---|---|
| Age | 0.579 | 0.447 | ||
| ≤45 | 13(48.1) | 5(35.7) | ||
| >45 | 14(51.9) | 9(64.3) | ||
| Gender | 0.131 | 0.717 | ||
| Female | 17(63) | 8(57.1) | ||
| Male | 10(37) | 6(42.9) | ||
| Tumor size | 2.933 | 0.087 | ||
| ≤10mm | 8(29.6) | 8(57.1) | ||
| >10mm | 19(70.4) | 6(42.9) | ||
| Unilateral or Bilateral | 0.038 | 0.846 | ||
| Unilateral | 17(63) | 10(71.4) | ||
| Bilateral | 10(37) | 4(28.6) | ||
| Extrathyroidal invasion | 0.078 | 0.780 | ||
| YES | 2(7.4) | 0(0) | ||
| NO | 25(92.6) | 14(100) | ||
| Lymph node metastasis | 1.076 | 0.300 | ||
| YES | 9(33.3) | 7(50) | ||
| NO | 18(66.7) | 7(50) | ||
| AJCC | 0.000 | 1.000 | ||
| I+II | 18(66.7) | 9(64.3) | ||
| III+IV | 9(33.3) | 5(35.7) |